Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
23.3%
% of XLV's 60 holdings also in FMED
25.5%
% of FMED's 62 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 11.1% | 4.0% | 4.0% |
|
INTUITIVE SURGICAL INC | 3.5% | 4.5% | 3.5% |
|
BOSTON SCIENTIFIC CORP | 2.8% | 7.3% | 2.8% |
|
DANAHER CORP | 2.4% | 3.5% | 2.4% |
|
STRYKER CORP | 2.4% | 2.8% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FMED
|
ELI LILLY & CO | 9.6% |
|
JOHNSON & JOHNSON | 7.3% |
|
UNITEDHEALTH GROUP INC | 7.1% |
|
ABBVIE INC | 6.2% |
|
ABBOTT LABORATORIES | 4.4% |
|
MERCK & CO. INC. | 4.0% |
|
AMGEN INC | 3.1% |
|
GILEAD SCIENCES INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
PFIZER INC | 2.5% |
XLV Underweight Relative to FMED
|
BOSTON SCIENTIFIC CORP | -4.5% |
|
INSULET CORP | -4.0% |
 |
ARGENX SE ADR | -3.4% |
|
PENUMBRA, INC. | -3.2% |
|
UCB SA | -2.8% |
|
AGILON HEALTH INC | -2.8% |
|
ALNYLAM PHARMACEUTICALS INC | -2.8% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.6% |
|
EXACT SCIENCES CORP | -2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.5% |